A Closer Look at S1P Immunomodulator Therapeutics to Improve Outcomes in Patients with Relapsing Multiple Sclerosis
WebcastFaculty
OVERVIEW
A Closer Look at S1P Immunomodulator Therapeutics to Improve Outcomes in Patients with Relapsing Multiple Sclerosis is organized by Academic CME and will be held during Apr 03, 2017 - Apr 02, 2018.
The target audience for this medical event is Neurologists, and other healthcare professionals who care for patients with MS. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Discuss the recent scientific advancements of emerging S1P immunomodulators.
• Analyze the current clinical trial data concerning S1P efficacy and safety including, head to head superiority data and add-on therapy data.
• Apply the most current evidence-based medicine to develop individualized treatment plans for the interprofessional team to manage patients with relapsing multiple sclerosis.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Neurologists, and other healthcare professionals who care for patients with MS. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Discuss the recent scientific advancements of emerging S1P immunomodulators.
• Analyze the current clinical trial data concerning S1P efficacy and safety including, head to head superiority data and add-on therapy data.
• Apply the most current evidence-based medicine to develop individualized treatment plans for the interprofessional team to manage patients with relapsing multiple sclerosis.
Additional details will be posted as soon as they are available.
SPECIALITIES
Neurology
Quick Links